PAPER Zhang YY, Fan YC, Wang M, Wang D, Li XH
SEARCH RESULTS
331007 RESULTS
PAPER Festa EK, Ott BR, Manning KJ, Davis JD, Heindel WC
Effect of cognitive status on self-regulatory driving behavior in older adults: an assessment of naturalistic driving using in-car video recordings.
J Geriatr Psychiatry Neurol. 2013 Mar;26(1):10-8. PubMed: 23385363PAPER de Bruijn RF, Schrijvers EM, de Groot KA, Witteman JC, Hofman A, Franco OH, Koudstaal PJ, Ikram MA
The association between physical activity and dementia in an elderly population: the Rotterdam Study.
Eur J Epidemiol. 2013 Mar;28(3):277-83. PubMed: 23385659PAPER Rushworth JV, Griffiths HH, Watt NT, Hooper NM
Prion Protein-mediated Toxicity of Amyloid-β Oligomers Requires Lipid Rafts and the Transmembrane LRP1.
J Biol Chem. 2013 Mar 29;288(13):8935-51. PubMed: 23386614Željko Svedruzic on Déjà Vu? AD Patients Again Look Worse on γ-Secretase Inhibitor
COMMENT To understand why semagacestat and avagacestat failed, we need to understand the molecular properties of those compounds. Enzymatic mechanism studies offer insights into why those compounds can facilitate cognitive decline, and why current drug developmen
Who Will Progress to AD? Brain Microstructure Offers Clues
RESEARCH NEWS 2013-02-07 Research News Subtle alterations in the brain may help predict if people with mild cognitive impairment (MCI) will progress to Alzheimer’s disease (AD), according to a small study published in the January 30 Journal of Neuroscience. Using diffusion magnet
In Case You Wondered: Neurodegenerative Diseases Are Not Contagious
RESEARCH NEWS 2013-02-07 Research News Mounting evidence suggests that toxic proteins that cause Alzheimer's, Parkinson's, and other neurodegenerative diseases spread from neuron to neuron in a slow crawl through the brain. That news has sparked some concern among the m
PAPER Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I, Bubacco L, de Bernard M
Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.
PLoS One. 2013;8(1):e55375. PubMed: 23383169PAPER Russo I, Bubacco L, Greggio E
Exosomes-associated neurodegeneration and progression of Parkinson's disease.
Am J Neurodegener Dis. 2012;1(3):217-25. PubMed: 23383394PAPER McCarthy JM, Franke M, Resenberger UK, Waldron S, Simpson JC, Tatzelt J, Appelhans D, Rogers MS
Anti-prion drug mPPIg5 inhibits PrP(C) conversion to PrP(Sc).
PLoS One. 2013;8(1):e55282. PubMed: 23383136PAPER Salih BA
Prions. The mysterious infectious agents.
Neurosciences (Riyadh). 2004 Jan;9(1):11-8. PubMed: 23377297PAPER Dexter DT, Jenner P
Parkinson disease: from pathology to molecular disease mechanisms.
Free Radic Biol Med. 2013 Feb 4; PubMed: 23380027PAPER Verma A, Tandan R
RNA quality control and protein aggregates in amyotrophic lateral sclerosis: a review.
Muscle Nerve. 2013 Mar;47(3):330-8. PubMed: 23381726PAPER Labandeira-Garcia JL, Rodriguez-Pallares J, Rodríguez-Perez AI, Garrido-Gil P, Villar-Cheda B, Valenzuela R, Guerra MJ
Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.
Am J Neurodegener Dis. 2012;1(3):226-44. PubMed: 23383395PAPER Zhou YF, Liao SS, Luo YY, Tang JG, Wang JL, Lei LF, Chi JW, Du J, Jiang H, Xia K, Tang BS, Shen L
SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity.
PLoS One. 2013;8(1):e54214. PubMed: 23382880Current Filters
No filters selected